Do Not Copy Penalties Apply
|
|
- Luke Clarke
- 5 years ago
- Views:
Transcription
1 May Vo l u m e 9 Issue 5 Copyright 2010 Original Articles Journal of Drugs in Dermatology A Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars Oliver A. Perez MD, a Martha H. Viera MD, b Jitendra K. Patel MD, b Sailesh Konda MD, b Sadegh Amini MD, b Ran Huo MD, b Deborah Zell MD, b Sujatha Tadicherla MD, b Brian Berman MD PhD b Abstract a Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA b University of Miami, Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, FL Background: Onion extract gel (OE) and 0.5% hydrocortisone, silicone and vitamin E lotion (HSE) are two over-the-counter preparations used to enhance the cosmesis of keloids and hypertrophic scars. Objective: To determine the tolerability and efficacy of OE versus HSE versus placebo in subjects with keloids and hypertrophic scars. Methods: Thirty subjects ( 18 years) with keloids or hypertrophic scars were randomly assigned to one of three study preparations for 16 weeks. Scar volume was measured at baseline and weeks 4, 8, 12 and 16. Subjects and blinded investigators assessed scar parameters (induration, erythema, pigmentation alteration, pain, itching, tenderness and cosmetic appearance) and patient satisfaction at each visit using a visual analog scale (VAS). Data analysis included: mean percentage change (MPC) for subjects completing the study (n=15); the mixed model test to determine differences between the groups over time; and the Kruskal-Wallis test for the analysis of differences in subjects satisfaction within the three groups over 16 weeks for subjects who completed at least one follow-up visit (n=21). Results: All three preparations were well tolerated with the exception of a mild acneiform-like eruption in one OE patient. Significant improvements were obtained with OE in volume, length, width and induration and with HSE in volume, length, induration, erythema and pigmentation alteration. There was a trend showing that a higher percentage of subjects were satisfied with OE than with HSE or placebo. The Mix Model Analysis (MMA) showed significant improvements with OE over placebo in investigator cosmetic assessment, lesion induration, pigmentation and tenderness and with HSE over placebo in investigator cosmetic assessment, lesion induration, pigmentation and erythema. Improvements in erythema and pigmentation were significantly greater in HSE than in OE. Conclusion: Both OE and HSE were more effective than placebo in the management of hypertrophic scars and keloids. Introduction Keloids and hypertrophic scars are benign fibrous overgrowths of scar tissue that result from abnormal response to trauma. 1 Alterations in fibroblast function lead to the production of excessive dense fibrous tissue, which extends beyond the boundaries of the original wound in keloids and remains confined to the original margins in hypertrophic scars. 2 Keloids are more common in African Americans, individuals younger than 30 years of age and those with atopic symptoms. 3 6 They can cause significant disfigurement and psychological distress as well as symptoms such as tenderness, pain and pruritus. 2 Hypertrophic scars are raised, erythematous, pruritic, fibrous lesions associated with contractures of healing tissue and usually undergo partial spontaneous resolution over time. 7 At the present time, there is no therapeutic modality considered to be universally safe and effective for the treatment of keloids. 8 Current treatment options for keloids and hypertrophic scars include surgical excision, radiation, laser treatment, intralesional corticosteroid injections, silicone gel sheeting, compression/occlusion, 5-fluorouracil and cryotherapy. It should be noted that 0.5% hydrocortisone, silicone, vitamin E lotion (HSE) (Scarguard, Scarguard Labs (Red Rock Laboratories LLC, Great Neck, NY) and onion extract gel (OE) (Mederma, Merz Pharmaceuticals, LLC. Greensboro, NC) are widely used over-the-counter medications for the treatment of keloids and hypertrophic scars. HSE solution is based on occlusion therapy and a speciallyformulated flexible collodion developed to improve the appearance of scars. The clear liquid formulation dries rapidly and forms a protective film after application to the skin. Many dermatologists and plastic surgeons have incorporated HSE into their post-surgical regimen. It has been anecdotally reported that the product has a beneficial effect in the stimulation of endogenous collagenase production. 9 Eisen conducted an open-label pilot study with Scarguard (Scarguard Labs [Red Rock Laboratories], LLC, Great Neck, NY). After eight weeks of treatment, nine out of 12 patients reported a reduction in erythema and overall appearance, six patients reported a decrease in induration and five patients noted the scar was less raised. 9
2 515 OE is a topical gel with a botanical extract derived from Allium cepa (Cepalin ). Patients value this remedy because of its ease of use, relatively low cost and widespread availability. OE exhibits anti-inflammatory, bacteriostatic and collagen downregulatory properties and has been shown to improve collagen organization in a rabbit ear model. 10,11 Jackson et al. found no significant differences in erythema and pruritus between preand post-treatment evaluations after one month of three times daily applications of OE gel for the prophylaxis of 17 Mohs micrographic surgery scars. 25 Another double-blinded trial evaluating 97 patients with new and old scars assigned to OE gel and placebo gel control groups found the only significant difference to be patient-reported improvements of a softer, less noticeable scar at two months. 26 No differences were noted with respect to physician-measured appearance and size and patient-measured erythema and elevation. Recently, Chung and colleagues conducted a double-blinded, split-scar study of 24 patients with new surgical wounds and found that OE gel did not improve scar appearance, erythema and hypertrophy when compared with a petroleum-based ointment. 27 However, all the patients in this study were elderly Caucasians, a group at low risk for the development of hypertrophic scars and keloids. In this study, the authors observed the same response of subject satisfaction with OE as they found in the aforementioned study. 26 Patients with keloids and hypertrophic scars are frequently frustrated due to the lack of an optimal treatment modality that could offer fast results with good cosmetic outcomes, few adverse events and low recurrence rates at low cost. This issue tends to prompt patients to try over-the-counter alternatives, generating a big market for these kinds of treatments. The purpose of this study was to determine efficacy and safety of two popular overthe-counter agents (i.e., HSE and OE) in subjects with hypertrophic scars or keloids in a blinded, placebo-controlled, prospective fashion. In this study, the primary endpoint was the assessment of the target scar by the blinded-investigator and subject and the secondary endpoints included volume and color changes. Patients, Materials and methods Subjects were recruited by a sub-investigator for this IRB-approved, principal investigator-initiated study through internal advertisements placed at hospitals and clinics within the University of Miami Miller School of Medicine and external advertisements on the Miami-Dade Metrorail. A total of 30 subjects, 18 years of age or older, with a keloid or hypertrophic scar with a diameter of 0.5 to 2.5 cm were enrolled March 2006 and March Follow-up of the last study subject was completed in June Exclusion criteria included pregnancy, breast-feeding, uncontrolled diabetes or autoimmune disorders, scar treatment within one month, plans to receive other scar treatments during the study, scars not amenable to study medications, known sensitivity to ingredients of study medications or other concomitant skin conditions that could potentially interfere with the study. After agreeing to and signing the informed consent, subjects were evaluated in the authors research office and randomly assigned by another sub-investigator to receive one of three study drugs: HSE (Scarguard, Scarguard Labs, LLC, Inc. Great Neck, NY), OE (Mederma, Merz Pharmaceuticals, LLC. Greensboro, NC), or placebo (Cethaphil moisturizing lotion, Galderma Laboratories, L.P. Fort Forth, TX) for 16 weeks using a computer-generated randomization list. The code was kept on a secure computer unavailable to the blinded investigators throughout the study and was not revealed until the final results were analyzed. Subjects were instructed to apply HSE twice daily, OE three to four times daily, or placebo twice daily, according to their respective instructions as found in the package inserts. During sequential evaluations at baseline and weeks 4, 8, 12 and 16, adverse events were noted, photographs were taken and the study scar volume was measured using an alginate impression. The impressions were placed on a precision scale with a readability of g and the scale was zeroed. Water was added until the impression was completely filled. The scale reading was converted into volume by utilizing the conversion of 1 g=1 cc based on the density of water. Subjects and the blinded investigator assessed the scar parameters (volume, length, width, height, induration, erythema, pigmentation alteration, pain, itching, tenderness and cosmetic appearance) at each visit with a visual analog scale (VAS), ranging from (0=best and 100=worst). At each visit, subjects also assessed satisfaction to treatment with a VAS, ranging from (0=not satisfied and 100=satisfied). Data analysis for subjects who completed the study (n=15) was performed using two-tailed Student s t test. The estimated effect of the treatments was stated by the percentage changes of the means measured at week 16 compared to baseline. To ensure completeness of data analysis, the mixed model test was also used to determine differences between the groups (HSE, OE and placebo) over 16 weeks. For the mixed model test, all available observations for each subject, including those who later dropped out, were incorporated into the analysis for weeks 4, 8 and 12. In addition, the Kruskal-Wallis test was conducted for the analysis of differences in subjects satisfaction within the three groups over 16 weeks. The significance level used in this study was set at 95% (P=0.05). Results Thirty subjects were enrolled in the study, with 10 subjects for each group. By week 4, a total of 21 subjects remained in the study, and by week 16 a total of 15 subjects (five in each study group) remained. No significant differences in gender, age or race were found between the groups. Demographic data, type of scar and scar anatomical localization in subjects who completed the study were included in the final analysis and summarized in Table 1. At week 16, HSE had a significant mean
3 516 percentage reduction in volume (P=0.01), length (P=0.02), induration (P<0.01), erythema (P<0.01) and pigmentation alteration (P<0.01) compared to baseline. HSE also demonstrated a significant mean percentage improvement of the cosmetic appearance, as per the investigator evaluation (P<0.01) and the subject assessment (P=0.04). OE had a significant mean percentage reduction in volume (P=0.01), length (P=0.02), width (P=0.02) and induration (P=0.03). Data from the placebo group showed a significant mean percentage reduction in volume (P=0.02) and a significant mean percentage improvement in cosmetic appearance, as per the subject assessment (P=0.01). The overall satisfaction of the products, defined as VAS 76, was positive for nine of 20 subject evaluations for HSE, 12 of 20 evaluations for OE and four of 20 evaluations for placebo over 16 weeks. Although the difference between groups for subject satisfaction was non-statistically significant (P=0.157, Kruskal-Wallis test), a trend was observed where a higher percentage of subjects were satisfied with OE than HSE and placebo (Figure 1). For the mixed model test, HSE showed significant improvement over placebo in four parameters, including investigator cosmetic assessment (P<0.01), lesion induration (P<0.001), pigmentation (P<0.001) and erythema (P=0.01). OE showed significant improvement over placebo in four parameters as well, including investigator cosmetic assessment (P<0.01), lesion induration (P<0.001), pigmentation (P<0.001) and tenderness (P<0.05). One subject from the OE group had an acneiform-like eruption at the site of study drug application which resolved after discontinuation of the study drug. Fifteen subjects were lost to follow-up during the study. Discussion The authors evaluated two popular over-the-counter agents containing HSE and OE for the treatment of keloids and hypertrophic scars. HSE combines the anti-inflammatory and antipruritic properties of hydrocortisone, with hydration and occlusion provided by silicone, and with the lubricant and moisturizing activity of vitamin E. In addition, silicone may also correct aberrant immunological processes, which, if left unchecked, may alter the tissue repair process and ultimately result in the formation of hypertrophic and keloid scars The proprietary extract in OE has been shown to soften scar tissue and to improve the color, texture and overall appearance of scars in controlled studies of human wound healing The authors found an improvement in more study parameters for HSE (seven of 12) than OE (four of 12) after 16 weeks when Table 1. Epidemiologic Data, Type of Scar and Anatomical Localization of the Scars in Subjects that Completed the Study and Were Included in the Final Analysis Subject # Age (yrs) HSE Sex Race Type of Scar Site Of Scar M White Hypertrophic Right Shoulder Penalties F Hispanic ApplyKeloid Leg (posterolateral) F Black Hypertrophic Right Groin F Black Keloid Left Buttock F Black Keloid Right Shoulder OE F Black Hypertrophic Leg (Anterlateral) M Black Keloid Posterior Chest F Black Keloid Right Ear M White Keloid Neck (Left Side) F Black Keloid Right Groin Placebo F Hispanic Keloid Anterior Chest M Hispanic Keloid Right Ear Lobe M Black Hypertrophic Right Anterior Chest F Black Keloid Right Anterior Chest F Black Keloid Right Anterior Chest
4 517 Figure 1. Mean percent improvement of keloid lesions by treatments, comparing the lesions between baseline and week 16. Note: An arrow denotes statistical significance (P<0.05). Two parameters showed worsening at week 16: Width of the lesion for the HSE group (18% worsening), and pigmentary alteration for the placebo group (11% worsening). Percentage Improvement (%) Volume Length Hydrocortisone, silicone, vitamin E lotion (HSE) Mean Percent Improvement of Lesion by Treatments Width Induration compared to baseline, although OE resulted in a greater improvement than both, HSE and placebo in volume, which was the only scar parameter assessed in an objective fashion. Placebo improved two keloid parameters at the end of the study including volume and cosmetic appearance which was attributed to 1) the use of cetearyl alcohol lotion containing dimethicone (silicone-base agent) and tochopheryl acetate (vitamin E), which have been used for the treatment of keloids and hypertrophic scars since they hydrate the stratum corneum, prevent transepidermal water loss and ultimately make scars and surrounding skin appear more smooth and flexible to the patient, and 2) the possible effect of time on some scars. However, when choosing the placebo, the authors anticipated a low probability that Cetaphil, without occlusion, at the administered dose, could have an effect on any of the scar parameters. Furthermore, at the end of the study the effect of HSE and OE was superior in number of parameters improved, and overall satisfaction of the product as defined above as obtaining more that 76 on a visual analog scale ranging from (0=not satisfied and 100=satisfied). The mixed model test was performed to assess for treatment efficacy over the course of the 16 weeks of the study, and showed that the treatments yielded significant improvements over placebo in four parameters for both OE (investigator cosmetic assessment, lesion induration, pigmentation and tenderness) and HSE (investigator cosmetic assessment, lesion induration, pigmentation and erythema). The authors results showed that HSE worked better than OE and placebo, however with the Kruskal-Wallis analysis the authors Erythema Onion extract gel (OE) Pigmentary Alteration Cosmetic (Investigator) Cosmetic (Subject) Placebo - cetearyl alcohol-based lotion demonstrated a trend towards higher satisfaction with the use of OE than with HSE and placebo. Further studies are needed, expanding the study population in order to increase the power and elicit statistically significant differences between the groups. Conclusion Overall, the combination of 0.5% hydrocortisone, silicone and vitamin E lotion (HSE) was better than the onion extract and placebo for the treatment of keloids and hypertrophic scars. Onion extract also demonstrated in our study to be effective compared with placebo in the management of these scars. These two popular over-the-counter agents offered some degree of improvement, and they could be combined with other therapeutic modalities to increase overall efficacy and obtain better cosmetic results. Disclosures Dr. Berman is a consultant for Red Rock Laboratories. Drs. Perez, Viera, Patel, Konda, Amini, Huo, Zell and Tadicherla have no conflicts of interest to disclose. 1. References Younai S, Nichter LS, Wellisz T, et al. Modulation of collagen synthe- sis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg. 1994;33: Berman B, Amini S, Viera M. Keloid and hypertrophic scar. WebMD Health Professional Network. Available at Accessed on April 14, Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: A comprehensive review. Plast Reconstr Surg. 1989;84: Abrams BJ, Benedetto AV, Humeniuk HM. Exuberant keloidal formation. J Am Osteopath Assoc. 1993;93: Ketchum LD. Hypertrophic scars and keloids. Clin Plast Surg. 1977;4: Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104: Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997;77(3): Karrer S. Therapy of keloids. Hautarzt. 2007;58(11): Eisen D. A pilot study to evaluate the efficacy of Scarguard in the prevention of scars. Intern J Dermatol. 2004;5(2). 10. Augusti KT. Therapeutic values of onion (allium cepa L.) and garlic (allium sativum L.). Indian J Exp Biol. 1996;34: Saulis AS, Mogford JH, Mustoe TA. Effect of mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg. 2002;110: Musgrave MA, Umraw N, Fish JS, et al. The effect of silicone gel sheets on perfusion of hypertrophic burn scars. J Burn Care Rehabil. 2002;23: Branagan M, Chenery DH, Nicholson S. Use of infrared attenuated total reflectance spectroscopy for the in vivo measurement of hy-
5 dration level and silicone distribution in the stratum corneum following skin coverage by polymeric dressings. Skin Pharmacol Appl Skin Physiol. 2000;13: Chang CC, Kuo YF, Chiu HC, et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res. 1995;59: Phillips TJ, Gerstein AD, Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids. Dermatol Surg. 1996;22: Quinn KJ, Evans JH, Courtney JM, et al. Non-pressure treatment of hypertrophic scars. Burns Incl Therm Inj. 1985;12: Ricketts CH, Martin L, Faria DT, et al. Cytokine mrna changes during the treatment of hypertrophic scars with silicone and nonsilicone gel dressings. Dermatol Surg. 1996;22: Suetak T, Sasai S, Zhen YX, Tagami H. Effects of silicone gel sheet on the stratum corneum hydration. Br J Plast Surg. 2000;53: Gilman TH. Silicone sheet for treatment and prevention of hypertrophic scar: A new proposal for the mechanism of efficacy. Wound Repair Regen. 2003;11: Hirshowitz B, Lindenbaum E, Har-Shai Y, et al. Static-electric field induction by a silicone cushion for the treatment of hypertrophic and keloid scars. Plast Reconstr Surg. 1998;101: Kuhn MA, Moffit MR, Smith PD, et al. Silicone sheeting decreases fibroblast activity and downregulates TGFbeta2 in hypertrophic scar model. Int J Surg Investig. 2001;2: Hanasono MM, Lum J, Carroll LA, et al. The effect of silicone gel on basic fibroblast growth factor levels in fibroblast cell culture. Arch Facial Plast Surg. 2004;6: Eishi K, Bae SJ, Ogawa F, et al. Silicone gel sheets relieve pain and pruritus with clinical improvement of keloid: Possible target of mast cells. J Dermatol Treat. 2003;14: Mederma. Available at: Accessed on April 14, Jackson BA, Shelton AJ. Pilot study evaluating topical onion extract as treatment for postsurgical scars. Dermatol Surg. 1999;25: Clarke L, Baker B, Trahan C, et al. A prospective double-blinded study of mederma skin care versus placebo for post-traumatic scar reduction. Cosm Dermatol. 1999;12: Chung VQ, Kelley L, Marra D, Jiang SB. Onion extract gel versus petrolatum emollient on new surgical scars: Prospective doubleblinded study. Dermatol Surg. 2006;32: Address for Correspondence Brian Berman, MD, PhD University of Miami Department of Dermatology & Cutaneous Surgery 1600 NW 10 th Ave Room 2023 A (R250) Miami, FL Phone:... (305) Fax:... (305)
Effects of silicone gel on burn scars
burns 35 (2009) 70 74 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/burns Effects of silicone gel on burn scars Mahnoush Momeni a, Farhad Hafezi b, *, Hossein Rahbar 1, Hamid
More informationClinical Summary. Introduction. What are Scars? There are three main types of scars:
Introduction Clinical Summary Since the introduction of silicone in the early 1980s for the prevention and treatment of hypertrophic & keloid scars, it s therapeutic effects have been well documented in
More informationClinical Summary. treatment and prevention of hypertrophic scars have been well documented in the literature.
Introduction: Introduction: Since the introduction of silicone in the early 1980s, its therapeutic effects on predominantly the i, ii treatment and prevention of hypertrophic scars have been well documented
More informationEffectiveness of external topical medications in the treatment of keloid scars: a review
Hong Kong J. Dermatol. Venereol. (2016) 24, 120-128 Review Article Effectiveness of external topical medications in the treatment of keloid scars: a review S Wang and J Yap Keloid scars may cause itch,
More informationResearch Article Effectiveness of Onion Extract Gel on Surgical Scars in Asians
Dermatology Research and Practice Volume 2012, Article ID 212945, 6 pages doi:10.1155/2012/212945 Research Article Effectiveness of Onion Extract Gel on Surgical Scars in Asians Kumutnart Chanprapaph,
More informationThis chapter gives background information about the scarring process. Treatment options for problematic scars are also discussed.
Chapter 15 SCAR FORMATION KEY FIGURES: Hypertrophic scar Buried dermal suture This chapter gives background information about the scarring process. Treatment options for problematic scars are also discussed.
More informationComparison of intralesional triamcinolone and intralesional verapamil in the treatment of keloids
Original Article Comparison of intralesional triamcinolone and intralesional verapamil in the treatment of keloids Muhammad Uzair, Ghazala Butt, Khawar Khurshid, Sabrina Suhail Pal Department of Dermatology,
More informationEfficacy and Safety of an Advanced Formula Silicone Gel for Prevention of Post-Operative Scars
Dermatol Ther (Heidelb) (2013) 3:157 167 DOI 10.1007/s13555-013-0036-8 ORIGINAL RESEARCH Efficacy and Safety of an Advanced Formula Silicone Gel for Prevention of Post-Operative Scars Bikash Medhi Rakesh
More informationIs Pulse-Dye Laser Therapy an Effective Treatment for Burn Scars?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2014 Is Pulse-Dye Laser Therapy an Effective
More informationControlled Corticosteroid Introduction Using Superficial Therapeutic Pressure for the Treatment of Keloids
Case Report Controlled Corticosteroid Introduction Using Superficial Therapeutic Pressure for the Treatment of Keloids Alex Levenberg, MD, GCP, ACRP,* Marion Moers-Carpi, MD *Beit Ha rofeem Plastic Surgery
More informationThe Patient and Observer Scar Assessment Scale: A Reliable and Feasible Tool for Scar Evaluation
The Patient and Observer Scar Assessment Scale: A Reliable and Feasible Tool for Scar Evaluation Lieneke J. Draaijers, M.D., Fenike R. H. Tempelman, M.D., Yvonne A. M. Botman, M.D., Wim E. Tuinebreijer,
More informationAbnormal Scars, Management Options
106) Edriss A. S., Měšťák J. Charles University in Prague, First Faculty of Medicine and University Hospital Na Bulovce, Department of Plastic Surgery, Prague, Czech Republic Received April 28, 2008; Accepted
More informationIs the Use of Triamcinolone (TAC) in Combination with 5-Fluorouracil (5-FU) More Effective than TAC Alone in the Treatment of Keloid Scars?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is the Use of Triamcinolone (TAC)
More informationCLINICAL DATA _SILICON GEL
CLINICAL DATA _SILICON GEL REVIEW ARTICLE A Review of the Biologic Effects, Clinical Efficacy, and Safety of Silicone Elastomer Sheeting for Hypertrophic and Keloid Scar Treatment and Management BRIAN
More informationContractubex Versus Corticosteroid Phonophoresis on Burn Hypertrophic Scar
Med. J. Cairo Univ., Vol. 84, No. 2, June: 63-67, 2016 www.medicaljournalofcairouniversity.net Contractubex Versus Corticosteroid Phonophoresis on Burn Hypertrophic car WAFAA H. BORHAN, Ph.D.*; ALAH EL-DIN
More informationTo order reprints or e-prints of JDD articles please contact JDD
June 2017 534 VOLUME 16 ISSUE 6 Copyright 2017 ORIGINAL ARTICLE Journal of Drugs in Dermatology The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris Lauren K. Hoffman
More informationOriginal Article ABSTRACT
Original Article Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids FX Margaret Shanthi, Kalpana Ernest, Prema Dhanraj 1 Departments
More informationSurgery and Perioperative Intralesional Corticosteroid Injection for Treating Earlobe Keloids: A Korean Experience
Ann Dermatol Vol. 21, No. 3, 2009 ORIGINAL ARTICLE Surgery and Perioperative Intralesional Corticosteroid Injection for Treating Earlobe Keloids: A Korean Experience Jin Young Jung, M.D., Mi Ryung Roh,
More informationTopical Silicone Sheet Application in the Treatment of Hypertrophic Scars and Keloids
Niessen copy_jcad Master 10/3/16 11:14 AM Page 7 A B S T R A C T Objective: Since the early 1980s, topical silicone sheets have been used in the treatment of hypertrophic scars and keloids. This study
More informationClinical Study Synopsis for Public Disclosure
Clinical Study Synopsis for Public Disclosure These results are supplied for informational purposes only in the interest of scientific disclosure. The synopsis may include approved and non-approved uses,
More informationD E R M A T O L O G Y
We customize individual prescriptions for the specific needs of our patients. F E B R U A R Y 2 0 1 3 I N S I D E T H I S I S S U E : Psoriasis Vulgaris 2 Atopic Dermatitis 3 P R E S C R I P T I O N C
More informationMark S. Nestor, MD, PhD a,b. Brian Berman, MD, PhD a,b. Aventura, FL. University of Miami Miller School of Medicine Miami, FL
Mark S. Nestor, MD, PhD a,b Brian Berman, MD, PhD a,b a,b Center for Clinical and Cosmetic Research Aventura, FL a,b Department of Dermatology and Cutaneous Surgery University of Miami Miller School of
More informationPATHOLOGICAL TYPES OF SCARS AND THEIR IMPACT ON TREATMENT. Dr. Tarek Ahmed Said Professor of Plastic Surgery Cairo University 2015
PATHOLOGICAL TYPES OF SCARS AND THEIR IMPACT ON TREATMENT Dr. Tarek Ahmed Said Professor of Plastic Surgery Cairo University 2015 Pathological Types of Scars Atrophic Scars Normotrophic Scars Hypertrophic
More informationKeloid disease: clinical relevance of single versus multiple site scars
The British Association of Plastic Surgeons (2005) 58, 28 37 Keloid disease: clinical relevance of single versus multiple site scars A. Bayat b,c,d, *, G. Arscott a, W.E.R. Ollier c, D.A. Mc Grouther b,
More informationThe Effects of Topical Agent (Kelo-Cote or Contractubex) Massage on the Thickness of Post-Burn Scar Tissue Formed in Rats
The Effects of Topical Agent (Kelo-Cote or Contractubex) Massage on the Thickness of Post-Burn Scar Tissue Formed in Rats Won Jin Ko 1, Young Cheon Na 1,3, Bum Sin Suh 1, Hyeon A Kim 1, Woo Hoe Heo 1,
More informationDO NOT DUPLICATE. Negative pressure wound therapy (NPWT) has revolutionized the
Original research WOUNDS 2013;25(4):89 93 From the Aesthetic and Plastic Surgery Institute, University of California Irvine, Orange, CA and Long Beach Memorial Medical Center, Long Beach, CA Address correspondence
More informationCurrent Concepts in Burn Rehabilitation
Current Concepts in Burn Rehabilitation 7 th Congress of the Baltic Association of Rehabilitation Tallinn, Estonia September 2010 R. Scott Ward, PT, PhD Professor and Chair Department of Physical Therapy
More informationA Bio-Oil guide to Scars
A Bio-Oil guide to Scars ii The material in this brochure has been drawn from various sources and collated by Bio-Oil to provide one user-friendly reference on scars. Contents What is a scar? 2 Why do
More informationYOUR KELO-COTE GUIDE TO LIVING WITH YOUR SURGICAL SCAR
YOUR KELO-COTE GUIDE TO LIVING WITH YOUR SURGICAL SCAR CONTENTS WHAT IS THE DEFINITION OF A SCAR? 3 WHAT TYPES OF SCARS ARE THERE? 3 SCARS RESULTING FROM SURGERY 4 HOW COMMON ARE SCARS? 4 WHY DO THEY FORM?
More informationAn epidemiologic study by Kantar Health (2009) Original Article Reconstructive
Original Article Reconstructive The Use of Silgel STC-SE, a Topical Silicone Gel for the Treatment and Reduction of Hypertrophic and Keloid Scars Sharon A. Stewart, PhD, MSc Greig M. G. Dougall, MSc Erica
More informationA Pilot Study to Investigate the Efficacy of Tobramycin Dexamethasone Ointment in Promoting Wound Healing
Dermatol Ther (2012) 2:12 DOI 10.1007/s13555-012-0012-8 ORIGINAL RESEARCH A Pilot Study to Investigate the Efficacy of Tobramycin Dexamethasone Ointment in Promoting Wound Healing Rachel Andrew Gwendolyn
More informationDuring the last 20 years, the number of topical
THERAPEUTICS FOR THE CLINICIAN Cumulative Irritation Potential of Adapalene 0.1% Cream and Gel Compared With Tretinoin Microsphere 0.04% and 0.1% Jonathan S. Dosik, MD; Kenneth Homer, MS; Stéphanie Arsonnaud
More informationFast acting Complex formulations Clinically proven ingredients Economical price
Fast acting Complex formulations Clinically proven ingredients Economical price UK s top selling Professional Skincare PharmaClinix Ltd, Unit 3 Issigonis House, Cowley Road, London, W3 7UN, UK Scar Repairex
More informationPOSTOPERATIVE SCAR MANAGEment
ONLINE FIRST ORIGINAL ARTICLE Comparison of Effectiveness of Silicone Gel Sheeting With Microporous Paper Tape in the Prevention of Hypertrophic Scarring in a Rabbit Model Travis T. Tollefson, MD; Faranak
More informationA Keloid Edge Precut, Preradiotherapy Method in Large Keloid Skin Graft Treatment
A Keloid Edge Precut, Preradiotherapy Method in Large Keloid Skin Graft Treatment WENBO LI, MD, YOUBIN WANG, MD, XIAOJUN WANG, MD, AND ZHIFEI LIU, MD* BACKGROUND Keloids are scars that extend beyond the
More informationKeloids. Disclaimer. Multimedia Health Education
Disclaimer This movie is an educational resource only and should not be used to manage your health. All decisions about the management of must be made in conjunction with your Physician or a licensed healthcare
More informationKELO-COTE Silicone Gel For Scar Treatment: First Experience of Application in Russia
KELO-COTE Silicone Gel For Scar Treatment: First Experience of Application in Russia Those who have deformities, scars, and pigmentations,dream of their reduction and complete removal, however, unfortunately,
More informationBACKGROUND. Pathologic Scars
Medical and Rehabilitation Innovations Laser Therapy for Hypertrophic Scars & Keloids in Burns 2016 BACKGROUND Laser therapy has recently emerged as a promising option for treatment of hypertrophic scars
More informationInternational Journal of Medical Science and Education
International Journal of Medical Science and Education www.ijmse.com Original Research Article pissn- 2348 4438 eissn-2349-3208 A PROSPECTIVE STUDY OF POST BURN CONTRACTURE: INCIDENCE, PREDISPOSING FACTORS,
More informationCLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS
CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS BACKGROUND Efforts to improve fractional ablative laser systems have led to the development of
More informationA Pilot Study. Name of investigational product:
An Open Label, Multi Center Clinical Study to Evaluate the Efficacy and Safety of a New Topical Cosmeceutical in Relieving the Redness, Scaling and Flaking Associated with Severe Skin Conditions A Pilot
More informationJill Hackett ( address: 4 th year undergraduate occupational therapy student, University of Western Sydney
There is evidence (level 1b) that non-silicone polyurethane gel dressings are significantly more effective in reducing the cosmetic severity of mature hypertrophic scars than silicone gel dressings 1 Prepared
More informationWhat is an otoplasty?
What is an otoplasty? Otoplasty in an operation performed to reduce one or both prominent ears. Children with prominent ears have excess cartilage in the bowl or concha that protruded the ear out away
More informationComparison of Efficacy of Herbal Extract Plus Silicone Gel and Silicone Gel for the Prevention Postburn Hypertrophic Scars
Comparison of Efficacy of Herbal Extract Plus Silicone Gel and Silicone Gel for the Prevention Postburn Hypertrophic Scars Kosin Nimpoonyakampong MD*, Lertpong Somcharit MD*, Nantaporn Namviriyachote Pham.D**,
More informationUpdate on Phase 2a Clinical Trial Results of RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars and Keloids
Update on Phase 2a Clinical Trial Results of RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars and Keloids Presenter: Pamela A. Pavco, PhD Chief Development Officer RXi Pharmaceuticals
More informationSurgical Excision Followed by Low Dose Rate Radiotherapy in the Management of Resistant Keloids
Original Article 81 Surgical Excision Followed by Low Dose Rate Radiotherapy in the Management of Resistant Keloids Ali Akbar Mohammadi 1 *, Mohammad Mohammadian Panah 2, Mohammad Reza Pakyari 1, Raziyeh
More informationThe Role of Topical Vitamin E in Scar Management: A Systematic Review
Research The Role of Topical Vitamin E in Scar Management: A Systematic Review Aesthetic Surgery Journal 2016, Vol 36(8) 959 965 2016 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and
More information1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study
1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study KRISTEL D. POLDER, MD, y APRIL HARRISON, PA-C, y LEIGH ELLEN EUBANKS, MD, y AND SUZANNE BRUCE, MD y BACKGROUND
More informationMichael Eugene Jones, Cherrell Jackee Hardy, Julie Marie Ridgway ABSTRACT INTRODUCTION. Article ID: MJO ********* How to cite this article
Jones et al. 14 CASE ORIGINAL REPORT ARTICLE PEER REVIEWED OPEN ACCESS Head and neck keloid management: A retrospective early review on a new approach using surgical excision, platelet rich plasma and
More informationAnalysis of Frequency of Use of Different Scar Assessment Scales Based on the Scar Condition and Treatment Method
Analysis of Frequency of Use of Different Scar Assessment Scales Based on the Scar Condition and Treatment Method Seong Hwan Bae, Yong Chan Bae Department of Plastic and Reconstructive, Pusan National
More informationTo update the management algorithm for pathologic scarring to reflect best practice standards at
Updated International Clinical Recommendations on Scar Management: Part 2 Algorithms for Scar Prevention and Treatment Michael H. Gold, MD,* Michael McGuire, MD, Thomas A. Mustoe, MD, x Andrea Pusic, MD,
More informationEarly View Article: Online published version of an accepted article before publication in the final form.
Early View Article: Online published version of an accepted article before publication in the final form. Journal Name: Edorium Journal of Otolaryngology Type of Article: Original Article Title: Head and
More informationA PROSPECTIVE STUDY ON AURICULAR BURNS
Int. J. Pharm. Med. & Bio. Sc. 2013 Ramesha K T et al., 2013 Research Paper ISSN 2278 5221 www.ijpmbs.com Vol. 2, No. 4, October 2013 2013 IJPMBS. All Rights Reserved A PROSPECTIVE STUDY ON AURICULAR BURNS
More informationLouisiana State University Medical Center - Regional Burn Center Shreveport, LA. The Management of Face and Neck Scars With Silon-STS
Louisiana State University Medical Center - Regional Burn Center Shreveport, LA The Management of Face and Neck Scars With Silon-STS KM Sittig; SB Abney; NS Classen; CM Saulsbery; KN Landry Louisiana State
More informationCpt code for excision of keloid scar on ear
Cpt code for excision of keloid scar on ear scar revision, debridement (eg, traumatic lacerations or avulsions), extensive undermining, stents or retention sutures. Necessary preparation includes creation
More informationAtopic dermatitis/ eczema (a condition that makes skin red and itchy):
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Atopic dermatitis/ eczema (a condition that makes skin red and itchy): Atopic dermatitis (AD) is a common skin condition with
More informationPREVENTION AND CURATIVE MANAGEMENT OF HYPERTROPHIC SCAR FORMATION
3 PREVENTION AND CURATIVE MANAGEMENT OF HYPERTROPHIC SCAR FORMATION ABSTRACT Although hypertrophic scarring commonly occurs following burns, many aspects such as incidence of and optimal treatment for
More informationClinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System
Plastic Surgery International Volume 00, Article ID 87448, 4 pages doi:0.55/00/87448 Clinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System Takamitsu Higashimori, Taro
More informationAll surgery carries some uncertainty and risk
Dr Mi chel s on@mi chel s onmd. com All surgery carries some uncertainty and risk While scar revision is normally safe, there is always the possibility of complications. These may include infection, bleeding,
More informationAnseong Factory : 70-17, Wonam-ro, Wongok-myeon, Anseong-si, Gyeonggi-do , REPUBLIC OF KOREA
Care for tomorrow The Solution for Management HQ & Factory : 7, Hyeongjero4Beon-gil, Namsa-myeon, Cheoin-gu, Yong-in-si, Gyeonggi-do 449-884, REPUBLIC OF KOREA TEL: +8-3-33-33 / FAX: +8-3-33-34 Anseong
More informationComparision of efficacy of local administration of contractubex & corticosteroids for hypertrophic scar in maxillofacial region
Original Article Comparision of efficacy of local administration of contractubex & corticosteroids for hypertrophic scar in maxillofacial region 3 5 Muralee Mohan, B. Rajendra Prasad, S. M. Sharma, Tripthi
More informationPhotodamaged skin occurs as a result of its
Plasma Skin Resurfacing for Regeneration of Neck, Chest, and Hands: Investigation of a Novel Device TINA S. ALSTER, MD, AND SAILESH KONDA, BS BACKGROUND Many noninvasive treatments to rejuvenate photodamaged
More informationClinical Policy Title: Laser treatments for hypertrophic scars
Clinical Policy Title: Laser treatments for hypertrophic scars Clinical Policy Number: 17.02.07 Effective Date: June 1, 2017 Initial Review Date: May 19, 2017 Most Recent Review Date: May 19, 2017 Next
More informationIAD and its Severity Instrument
IAD and its Severity Instrument Designed and validated by WOC nurses and their faculty 2 WOC nurses established initial face validity Content and criterion validity via 9 WOC nurses in North Central Region
More informationTreatment of Warts with Candida Antigen Injection
Home Up Treatment of Warts with Candida Antigen Injection Vignette published in Archives of Dermatology, October, 2001 This full report published with the permission of the Archives of Dermatology. Rebecca
More informationA comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring
Arch Dermatol Res (015) 307:61 77 DOI 10.1007/s0003-015-157-0 REVIEW A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring G. P. Sidgwick 1 D. McGeorge
More informationThursday, 21 October :53 - Last Updated Thursday, 11 November :27
1 / 15 2 / 15 3 / 15 4 / 15 Pityriasis Alba Background Pityriasis alba is a nonspecific dermatitis of unknown etiology that causes erythematous scaly patches. These resolve and leave areas of hypopigmentation
More informationComparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars
Original Article Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars Neerja Puri Consultant Dermatologist, Punjab Health Systems Corporation,
More informationFrequently Asked Questions
1112:V15:05:PB1540 Frequently Asked Questions For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory Dear Doctor, Warm regards from Cipla Xterna!!! We, at Cipla Xterna, a dedicated
More informationSatisfaction with facial laceration repair by provider specialty in the emergency department
Clin Exp Emerg Med 15;2(3):179-183 http://dx.doi.org/.15441/ceem.15.5 Satisfaction with facial laceration repair by provider specialty in the emergency department eissn: 2383-4625 Original Article Sang-Jae
More informationPREPARING FOR YOUR MOHS SURGERY
Patient Education provided by Leslie Storey, MD Board Certified, Mohs Fellowship Trained, Dermatologist PREPARING FOR YOUR MOHS SURGERY 1 Your surgery date is: _ 2 Welcome...5 What is Mohs Surgery?...6
More informationBiologics in ACL: What s the Data?
Biologics in ACL: What s the Data? Jo A. Hannafin, M.D., Ph.D. Professor of Orthopaedic Surgery, Weill Cornell Medical College Attending Orthopaedic Surgeon and Senior Scientist Sports Medicine and Shoulder
More informationClinical Trial of BCT KoCarbonAg Silver Bandage
Clinical Trial of BCT KoCarbonAg Silver Bandage A Comparative Efficacy and Safety Study between Bio-Medical Carbon Technology Silver Bandage and Aquacel Ag Dressing In Obstetrical and Gynecological Post-Operation
More informationPREPARING FOR YOUR MOHS SURGERY
Patient Education provided by Leslie Storey, MD Board Certified, Mohs Fellowship Trained, Dermatologist PREPARING FOR YOUR MOHS SURGERY Welcome...5 Your surgery date is: What is Mohs Surgery?...6 When
More informationBoonlawat Homvises MD* * Department of Surgery, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
A Randomized Trial between Different Suture Materials (Polydioxanone vs. Poliglecaprone 25) and Different Suturing Techniques (Running Subcuticular Suture Alone vs. with Running Horizontal Mattress) in
More informationDisclosures. Laser Treatment of Scars. Options for Cutaneous Scarring. Laser Treatment of Erythematous Scars. Laser Scar Revision Scar Type
Fundamentals: Instrumentation, and Skin Type Paul M. Friedman, M.D. Director, Dermatology & Laser Surgery Center Clinical Assistant Professor University of Texas Medical School, Houston, TX Clinical Assistant
More informationThe Age and Sex Incidence of Keloids / Hypertrophic Scars in Calabar Metropolis, Cross River State from
ISSN 4-308 (Paper) ISSN 5-093X (Online) Vol.4, No.11, 014 The Age and Sex Incidence of Keloids / Hypertrophic Scars in Calabar Metropolis, Cross River State from 001-006 Udo-Affah, G. U.*, Eru, E. M.,
More informationBleomycin Tattooing as a Promising Therapeutic Modality in Large Keloids and Hypertrophic Scars
Bleomycin Tattooing as a Promising Therapeutic Modality in Large Keloids and Hypertrophic Scars FARAHNAZ FATEMI NAEINI, MD, JAMSHID NAJAFIAN, MD, AND KOOROSH AHMADPOUR, MD BACKGROUND Cryotherapy combined
More informationInteresting Case Series. Rhinophyma
Interesting Case Series Rhinophyma Jake Laun, BS, Jared Gopman, BS, Joshua B. Elston, MD, and Michael A. Harrington, MD Department of Surgery, Division of Plastic Surgery, University of South Florida Morsani
More informationORIGINAL ARTICLES. Philippine Jo u r n a l Of Ot o l a r y n g o l o g y-he a d An d Ne c k Su r g e r y Vo l. 27 No. 2 Ju ly De c e m b e r 2012
Michael Paolo M. Tapangco, MD 1 Waynn Neilsen Destriza, MD 1 Bernardo D. Dimacali, MD 1, 2 Mildred B. Olveda, MD 1 1 Department of Otolaryngology Head and Neck Surgery Ospital ng Makati 2 Department of
More informationScottish Medicines Consortium
Scottish Medicines Consortium imiquimod 5% cream (Aldara) No. (385/07) Meda Pharmaceuticals Ltd 04 April 2008 The Scottish Medicines Consortium has completed its assessment of the above product and advises
More informationProspective, Randomized, Blinded Study of a New Wound Closure Film Versus Cutaneous Suture for Surgical Wound Closure
Prospective, Randomized, Blinded Study of a New Wound Closure Film Versus Cutaneous Suture for Surgical Wound Closure F ELIX K UO, MD, D ENNIS L EE, MD, y AND G ARY S. R OGERS, MD z BACKGROUND Wound closure
More informationH. John Visser, DPM 1, E. Dennis Harris, MD 2, Peter Hurwitz 3, Derek Dietze 4
Presented at the 6th Annual Scar Club Conference (Montpellier, France) and the European Tissue Repair Society & the Wound Healing Society (Copenhagen, Denmark) Patient-Reported Outcomes and Perceptions
More informationAdvanced Skin Needling with Dermapen. Tony Chu Dermatology Unit Hammersmith Hospital London, UK
Advanced Skin Needling with Dermapen Tony Chu Dermatology Unit Hammersmith Hospital London, UK Applications Atrophic scarring face, back and chest Acne and chicken pox Facial rejuvenation Treatment of
More informationRevision of a Widened Scar Using Dermal Splinting Technique
ORIGINAL ARTICLE http://dx.doi.org/.7/.5...75 Arch Aesthetic Plast Surg 5;():758 pissn: 8 eissn: 8897 Archives of Revision of a Widened Scar Using Dermal Splinting Technique Sik Namgoong, JaeA Jung, DeokYeol
More informationEvaluation of Imuspora Tablets and Ointment (Multi-Ingredient Herbal Formulation) In the Management of Psoriasis: An Open Trial
Evaluation of Imuspora Tablets and Ointment (Multi-Ingredient Herbal Formulation) In the Management of Psoriasis: An Open Trial Background: D G Saple*, S Medhekar** & M Patil*** *Professor & Head, Department
More informationThe Effects of Multi-Growth Factors-Containing Cream on Post-Thyroidectomy Scars: A Preliminary Study
S Shin, et al pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 29, No. 3, 2017 https://doi.org/10.5021/ad.2017.29.3.314 ORIGINAL ARTICLE The Effects of Multi-Growth Factors-Containing Cream on Post-Thyroidectomy
More informationPeriocular skin cancer
Periocular skin cancer Information for patients Skin cancer involving the skin of the eyelid or around the eye is called a periocular skin cancer. Eyelid skin cancers occur most often on the lower eyelid,
More informationPRESCRIBING INFORMATION. Cream 0.025% Topical Corticosteroid
PRESCRIBING INFORMATION Pr PROPADERM (beclomethasone dipropionate) Cream 0.025% Topical Corticosteroid Valeant Canada LP 2150 St-Elzear Blvd. West, Laval, Quebec, Canada H7L 4A8 Date of preparation: October
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR GENERAL PRACTICE
AUGUST 2011 PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Hemorrhoids 2 Celiac Disease 3 PRESCRIPTION
More informationDO NOT DUPLICATE. Pediatric burns may be the result of scalding, fire, electrical
Quality of Pediatric Second-degree Burn Wound Scars Following the Application of Basic Fibroblast Growth Factor: Results of a Randomized, Controlled Pilot Study Kenji Hayashida, MD; and Sadanori Akita,
More informationSPECIAL TOPIC. Cosmetic Dermatology Center, McLean, VA b. Art of Skin, MD, Solana Beach, CA c. Dermatology Associates, Seattle, WA
December 2016 1557 Volume 15 Issue 12 Copyright 2016 ORIGINAL ARTICLES Journal of Drugs in Dermatology SPECIAL TOPIC A Clinical Evaluation of a Next Generation, Non-Invasive, Selective Radiofrequency,
More informationKeloids are an ongoing clinical challenge. Despite the
Keloids: Which treatment is best for your patient? Corticosteroid injections have proven effective for many patients, but other options may be more appropriate depending on the keloid s location. Melinda
More informationObjective To determine the immediate irritation effects and the irritation power of a particular materials.
SAFETY STUDIES 1.1 Skin Irritation through Open Patch Test 1.2 Skin Irritation through Patch Test. 1.3 Human Skin Irritation Test 1.4 Repeat Open Application Test 1.5 Test For Hypoallergenicity 1.6 Modified
More informationClearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
DOI: 10.1111/jdv.14516 JEADV SHORT REPORT Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? A. Borghi,* A. Virgili, S. Minghetti, G. Toni, M. Corazza Dipartimento di Scienze
More informationIs Avotermin Safe and Effective Treatment for Scar Improvement in Healthy Males and Females?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Is Avotermin Safe and Effective Treatment
More informationThe Beneficial Effects of Postrhinoplasty TapingFact or Fiction? Kyle A. Belek, MD, Ronald P. Gruber, MD
The Beneficial Effects of Postrhinoplasty TapingFact or Fiction? Kyle A. Belek, MD, Ronald P. Gruber, MD Rhinoplasty The Beneficial Effects of Postrhinoplasty Taping: Fact or Fiction? Kyle A. Belek, MD;
More informationChapter 1. General introduction and outine of the thesis
Chapter 1 General introduction and outine of the thesis Introduction Skin anatomy Skin covers the entire body and provides a barrier between the body and the outside world through its mechanical as well
More informationMicroneedling Therapy in Atrophic Facial Scars: An Objective Assessment
ORIGINAL ARTICLE Microneedling Therapy in Atrophic Facial Scars: An Objective Assessment Background: Atrophic facial scars are always a challenge to treat, especially the ones that are deep-seated and/or
More informationFall Series Webinars with Karen Allen CCH. Adjuncts In Constitutional Care: Scarring Prevention and Revision
Fall Series Webinars with Karen Allen CCH Adjuncts In Constitutional Care: Scarring Prevention and Revision Roadmap for Our Training Session Today Scarring: the good, the bad and the ugly Physiology of
More information